Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Padua, RA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 67 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Parrado, A; Chomienne, C; Padua, RA
      Retinoic acid receptor alpha (RAR alpha) mutations in human leukemia

      LEUKEMIA & LYMPHOMA
    2. McGlynn, AP; Padua, RA; Burnett, AK; Darley, RL
      Alternative effects of RAS and RAF oncogenes on the proliferation and apoptosis of factor-dependent FDC-P1 cells

      LEUKEMIA RESEARCH
    3. Padua, RA; West, RR
      Oncogene mutation and prognosis in the myelodysplastic syndromes

      BRITISH JOURNAL OF HAEMATOLOGY
    4. West, RR; Stafford, DA; White, AD; Bowen, DT; Padua, RA
      Cytogenetic abnormalities in the myelodysplastic syndromes and occupational or environmental exposure

      BLOOD
    5. Larghero, J; Zassadowski, F; Rousselot, P; Padua, RA; Degos, L; Chomienne, C
      Alteration of the PML proto-oncogene in leukemic cells does not abrogate expression of MHC class I antigens

      LEUKEMIA
    6. Padua, RA; Parrado, A; Larghero, J; Chomienne, C
      UV and clean air result in contamination-free PCR

      LEUKEMIA
    7. Carpentier, AF; Leonard, N; Lacombe, J; Zassadowski, F; Padua, RA; Degos, L; Daumas-Duport, C; Chomienne, C
      Retinoic acid modulates RAR alpha and RAR beta receptors in human glioma cell lines

      ANTICANCER RESEARCH
    8. Parrado, A; West, R; Jordan, D; Bastard, C; McKenna, S; Whittaker, JA; Bentley, P; White, D; Chomienne, C; Padua, RA
      Alterations of the retinoic acid receptor alpha (RAR alpha) gene in myeloid and lymphoid malignancies

      BRITISH JOURNAL OF HAEMATOLOGY
    9. PADUA RA; GUINN BA; ALSABAH A; SMITH M; TAYLOR C; PETTERSSON T; RIDGE S; CARTER G; WHITE D; OSCIER D; CHEVRET S; WEST R
      RAS, FMS AND P53 MUTATIONS AND POOR CLINICAL OUTCOME IN MYELODYSPLASIAS - A 10-YEAR FOLLOW-UP

      Leukemia
    10. PADUA RA; BARON KT; THYAGARAJAN B; CAMPBELL C; THAYER SA
      REDUCED CA2-DEFICIENT HUMAN-DIPLOID FIBROBLASTS( UPTAKE BY MITOCHONDRIA IN PYRUVATE DEHYDROGENASE)

      American journal of physiology. Cell physiology
    11. MCKENNA SL; HOY T; HOLMES JA; WHITTAKER JA; JACKSON H; PADUA RA
      FLOW CYTOMETRIC APOPTOSIS ASSAYS INDICATE DIFFERENT TYPES OF ENDONUCLEASE ACTIVITY IN HEMATOPOIETIC-CELLS AND SUGGEST A CAUTIONARY APPROACHTO THEIR QUANTITATIVE USE

      Cytometry
    12. MCGLYNN H; BAKER AH; PADUA RA
      BIOLOGICAL CONSEQUENCES OF A POINT MUTATION AT CODON-969 OF THE FMS GENE

      Leukemia research
    13. PADUA RA; PARRADO A; JORDAN D; BASTARD C; MCKENNA S; WHITTAKER J; BENTLEY P; BURNETT A; CHOMIENNE C
      SCREENING FOR RETINOIC ACID RECEPTOR-ALPHA (RAR-ALPHA) REARRANGEMENTSIN NON-APL IDENTIFIES A NOVEL FUSION GENE IN CMML

      British Journal of Haematology
    14. PADUA RA; PARRADO A; WEST R; JORDAN D; BASTARD C; MCKENNA S; WHITTAKER J; BENTLEY P; BURNETT A; CHOMIENNE C
      RETINOIC ACID RECEPTOR-ALPHA (RAR-ALPHA) GENE REARRANGEMENTS IN NONACUTE PROMYELOCYTIC LEUKEMIA (NON-APL)

      British Journal of Haematology
    15. PARRADO A; MCKENNA S; DELMER A; NOGUERA ME; BENTLEY P; WHITTAKER JA; SIGAUX F; CHOMIENNE C; PADUA RA
      THE PROMYELOCYTIC LEUKEMIA ZINC-FINGER (PLZF) TRANSCRIPTION FACTOR ISDEREGULATED IN CHRONIC LYMPHOCYTIC-LEUKEMIA

      British Journal of Haematology
    16. PADUA RA; WARREN N; GRIMSHAW D; SMITH M; LEWIS C; WHITTAKER J; LAIDLER P; WRIGHT P; DOUGLASJONES A; FENAUX P; SHARMA A; HORGAN K; WEST R
      THE CYSTIC-FIBROSIS DELTA-F508 GENE-MUTATIONS AND CANCER

      Human mutation
    17. GALLAGHER A; DARLEY RL; PADUA RA
      THE MOLECULAR-BASIS OF MYELODYSPLASTIC SYNDROMES

      Haematologica
    18. GALLAGHER A; DARLEY R; PADUA RA
      RAS AND THE MYELODYSPLASTIC SYNDROMES

      Pathologie et biologie
    19. MCGLYNN H; KAPELKO K; BAKER A; BURNETT A; PADUA RA
      ALLELIC LOSS OF THE FMS GENE IN ACUTE MYELOID-LEUKEMIA

      Leukemia research
    20. DARLEY RL; HOY TG; BAINES P; PADUA RA; BURNETT AK
      MUTANT N-RAS INDUCES ERYTHROID LINEAGE DYSPLASIA IN HUMAN CD34(+) CELLS

      The Journal of experimental medicine
    21. MCKENNA SL; PADUA RA
      MULTIDRUG-RESISTANCE IN LEUKEMIA

      British Journal of Haematology
    22. PADUA RA; GUINN B; ALSABAH A; SMITH M; TAYLOR C; PETTERSSON T; RIDGE S; CARTER G; WHITE D; OSCIER D; WEST R
      ONCOGENE MUTATIONS AND PROGNOSTIC SCORES PREDICT POOR SURVIVAL IN MYELODYSPLASIA

      Blood
    23. HOLDEN CP; PADUA RA; GEIGER JD
      REGULATION OF RYANODINE RECEPTOR CALCIUM-RELEASE CHANNELS BY DIADENOSINE POLYPHOSPHATES

      Journal of neurochemistry
    24. THYAGARAJAN B; PADUA RA; CAMPBELL C
      MAMMALIAN MITOCHONDRIA POSSESS HOMOLOGOUS DNA RECOMBINATION ACTIVITY

      The Journal of biological chemistry
    25. PADUA RA; NAGY JI; GEIGER JD
      SUBCELLULAR-LOCALIZATION OF RYANODINE RECEPTORS IN RAT-BRAIN

      European journal of pharmacology
    26. PARRADO A; PADUA RA; MCKENNA S; DELMER A; DUPAS S; DAVIS J; ZELENT A; LEGAL I; BENTLEY P; WHITTAKER J; SIGAUX F; CHOMIENNE C
      ABNORMAL PROMYELOCYTIC LEUKEMIA ZINC-FINGER (PLZF) EXPRESSION IN B-CLL

      Blood
    27. PADUA RA; GUINN B; SMITH M; WEST R; TAYLOR C; PETTERSSON T; RIDGE S; CARTER G; ALSABAH A; WHITE D; OSCIER D; JACOBS A
      P53, RAS AND FMS MUTATIONS AND POOR CLINICAL OUTCOME IN MYELODYSPLASIA - A 7-YEAR FOLLOW-UP

      Blood
    28. TAYLOR C; MCGLYNN H; CARTER G; BAKER AH; WARREN N; RIDGE SA; OWEN G; THOMPSON E; THOMPSON PW; JACOBS A; PADUA RA
      RAS AND FMS MUTATIONS FOLLOWING CYTOTOXIC THERAPY FOR CHILDHOOD ACUTELYMPHOBLASTIC-LEUKEMIA

      Leukemia
    29. GALLAGHER A; PADUA RA; ALSABAH A; HOY T; BURNETT AK; DARLEY RL
      ABERRANT EXPRESSION OF P21(RAS) BUT NOT P120(GAP) IS A COMMON FEATUREOF MYELODYSPLASIA

      Leukemia
    30. TAYLOR C; PADUA RA
      LOW-FREQUENCY OF RAS GENE-MUTATIONS AND ABSENCE OF MUTATIONS WITHIN THE FLR EXON OF NF1 IN PATIENTS WITH THERAPY-RELATED LEUKEMIAS - REPLY

      Leukemia
    31. BAKER AH; BALL S; MCGLYNN H; WHITTAKER JA; BURNETT AK; PADUA RA
      A C-TERMINAL FMS MUTATION IN A PATIENT WITH B-CELL MALIGNANCY

      Leukemia
    32. GUINN B; PADUA RA
      DO P53 MUTATIONS HAVE A ROLE IN THE INITIATION AND PROGRESSION OF LEUKEMIA

      The Cancer journal
    33. GUINN BA; SMITH M; PADUA RA; BURNETT A; MILLS K
      CHANGING P53 MUTATIONS WITH THE EVOLUTION OF CHRONIC MYELOID-LEUKEMIAFROM THE CHRONIC PHASE TO BLAST CRISIS

      Leukemia research
    34. TAYLOR C; HUGHES DC; ZAPPONE E; CAZZOLA M; CARTER G; JACOBS A; PADUA RA
      A SCREEN FOR RAS MUTATIONS IN INDIVIDUALS AT RISK OF SECONDARY LEUKEMIA DUE TO OCCUPATIONAL EXPOSURE TO PETROCHEMICALS

      Leukemia research
    35. BAKER A; CACHIA P; RIDGE S; MCGLYNN H; CLARKE R; WHITTAKER J; JACOBS A; PADUA RA
      FMS MUTATIONS IN PATIENTS FOLLOWING CYTOTOXIC THERAPY FOR LYMPHOMA

      Leukemia research
    36. KULICZKOWSKI K; DARLEY RL; JACOBS A; PADUA RA; HOY TG
      UP-REGULATION OF P21 RAS LEVELS IN HL-60 CELLS DURING DIFFERENTIATIONINDUCTION WITH DMSO, ALL-TRANS-RETINOIC ACID AND TPA

      Leukemia research
    37. GUINN BA; SMITH M; PADUA RA; BURNETT A; MILLS K
      CHANGING P53 MUTATIONS WITH THE EVOLUTION OF CHRONIC MYELOID-LEUKEMIAFROM THE CHRONIC PHASE TO BLAST CRISIS (VOL 19, PG, 519, 1995)

      Leukemia research
    38. GUINN BA; ALSABAH AI; HEWLETT C; PADUA RA
      ELEVATED LEVELS OF P53 PROTEIN IN THE NEUTROPHILS AND MONOCYTES OF A PATIENT WITH CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA OR POSSIBLE EARLY MYELODYSPLASIA

      Leukemia research
    39. CULLIGAN DJ; BOWEN DT; MAY A; WHITE D; PADUA RA; BURNETT AK
      REFRACTORY-ANEMIA WITH PRELEUKAEMIC POLYCLONAL HEMATOPOIESIS AND THE EMERGENCE OF MONOCLONAL ERYTHROPOIESIS ON DISEASE PROGRESSION

      British Journal of Haematology
    40. BAKER AH; CACHIA PG; TENNANT GB; WHITTAKER JA; WHITE D; STANLEY ER; BURNETT AK; PADUA RA
      A NOVEL CSF-1 BINDING-FACTOR IN A PATIENT IN COMPLETE REMISSION FOLLOWING CYTOTOXIC THERAPY FOR LYMPHOMA

      British Journal of Haematology
    41. NATH A; PADUA RA; GEIGER JD
      HIV-1 COAT PROTEIN GP120-INDUCED INCREASES IN LEVELS OF INTRASYNAPTOSOMAL CALCIUM

      Brain research
    42. PADUA RA; MCKENNA S; BUTLER PC; WILLIAMSGREGORY D; JORDAN D; SMITH M; WHITE D; WHITTAKER J; BENTLEY P; BURNETT AK; JACOBS A
      IDENTIFICATION OF RETINOIC ACID RECEPTOR-ALPHA (RAR-ALPHA) GENE REARRANGEMENTS IN LEUKEMIAS - CLONING OF A NOVEL RAR-ALPHA-PLZF (PROMYELOCYTIC LEUKEMIA ZINC-FINGER) FUSION IN A PATIENT WITH CHRONIC LYMPHOCYTIC-LEUKEMIA

      Blood
    43. MCKENNA SL; JACKSON H; PADUA RA; WHITTAKER JA; HOLMES JA
      TOPOISOMERASE-II-BETA MESSENGER-RNA EXPRESSION IN ACUTE MYELOID-LEUKEMIA - RELATIONSHIP TO CLINICAL OUTCOME

      Blood
    44. MCKENNA SL; HOY T; PADUA RA; WHITTAKER JA; HOLMES JA
      DETECTION OF DRUG-INDUCED APOPTOSIS IN CHRONIC LYMPHOCYTIC-LEUKEMIA USING THE NICK TRANSLATION ASSAY - CORRELATION WITH CLINICAL-RESPONSE

      Blood
    45. MCKENNA SL; WEST RR; WHITTAKER JA; PADUA RA; HOLMES JA
      TOPOISOMERASE-II-ALPHA EXPRESSION IN ACUTE MYELOID-LEUKEMIA AND ITS RELATIONSHIP TO CLINICAL OUTCOME

      Leukemia
    46. CACHIA PG; TAYLOR C; THOMPSON PW; TENNANT GB; MASTERS G; PETTERSSON T; WHITTAKER JA; BURNETT AK; JACOBS A; PADUA RA
      NON-DYSPLASTIC MYELODYSPLASIA

      Leukemia
    47. BAINES P; LIMAYE M; HOY T; PADUA RA; WHITTAKER J; ALSABAH A; BURNETT A
      IN-VITRO DRUG-RESISTANCE IN ACUTE MYELOID AND CHRONIC B-LYMPHOCYTIC LEUKEMIC BLASTS AND IN NORMAL BLOOD AND MARROW POPULATIONS

      Leukemia research
    48. SHUKLA VK; LAIDLER P; HORGAN K; HUGHES LE; PADUA RA; JASANI B
      IMMUNOHISTOCHEMICAL DETECTION OF METALLOTHIONEIN EXPRESSION AND ITS CORRELATION WITH RAS ACTIVATION IN MELANOMA

      Journal of surgical oncology
    49. PADUA RA; NAGY JI; GEIGER JD
      IONIC-STRENGTH DEPENDENCE OF CALCIUM, ADENINE-NUCLEOTIDE, MAGNESIUM, AND CAFFEINE ACTIONS ON RYANODINE RECEPTORS IN RAT-BRAIN

      Journal of neurochemistry
    50. GUINN BA; WALSH V; EVELY R; PADUA RA; BURNETT AK; MILLS KI
      MURINE 32D CELLS EXPRESSING BOTH B2-A2 AND B3-A2 SPLICED BCR-ABL MESSENGER-RNA HAVE ENHANCED GROWTH AND ENGRAFTMENT CHARACTERISTICS

      Blood
    51. BAKER AH; MCGLYNN H; CONLON FV; PADUA RA
      FMS PROMOTER STUDIES IN B-LYMPHOCYTES

      Blood
    52. GALLAGHER A; PADUA RA; ALSABAH A; BURNETT AK; DARLEY R
      P21RAS EXPRESSION IN LEUKEMOGENESIS AND HEMATOPOIESIS

      Blood
    53. GUINN BA; PADUA RA; BURNETT A; MILLS K
      P53 MUTATIONS INDICATE A CHANGING CLONAL EVOLUTION IN A PORTION OF CHRONIC MYELOCYTIC-LEUKEMIA PATIENTS

      Blood
    54. MCKENNA SL; WHITTAKER JA; PADUA RA; HOLMES JA
      TOPOISOMERASE-II EXPRESSION IN NORMAL HEMATOPOIETIC-CELLS AND CHRONICLYMPHOCYTIC-LEUKEMIA - DRUG-SENSITIVITY OR RESISTANCE

      Leukemia
    55. CACHIA PG; CULLIGAN DJ; CLARK RE; WHITTAKER JA; JACOBS A; PADUA RA
      CLONAL HEMATOPOIESIS FOLLOWING CYTOTOXIC THERAPY FOR LYMPHOMA

      Leukemia
    56. PADUA RA
      JACOBS,ALLAN, 1929-1993 - OBITUARY

      Leukemia
    57. BOWEN DT; PADUA RA; BURNETT AK; DECASTRO CM; KAUFMAN RE
      2 NEW POLYMORPHISMS BUT NO MUTATIONS OF THE KIT GENE IN PATIENTS WITHMYELODYSPLASIA AT POSITIONS CORRESPONDING TO HUMAN FMS AND MURINE W LOCUS MUTATIONAL HOT-SPOTS

      Leukemia
    58. BAINES P; LIMAYE M; HOY T; PADUA RA; WHITTAKER JA; BURNETT AK
      ROLE OF P-GLYCOPROTEIN IN IN-VITRO DRUG-RESISTANCE IN ACUTE MYELOID AND CHRONIC LYMPHOCYTIC LEUKEMIC BLASTS AND IN NORMAL HEMATOPOIETIC POPULATIONS

      Experimental hematology
    59. MCGLYNN H; BAKER AH; DIBB NJ; BURNETT AK; PADUA RA
      COLONY-STIMULATING FACTOR-I RECEPTOR (CSF-1R) INTERNALIZATION STUDIESIN HEMATOPOIETIC-CELLS

      Experimental hematology
    60. PADUA RA; NAGY JI; GEIGER JD
      IONIC STRENGTH-DEPENDENT EFFECTS OF CALCIUM, ADENINE-NUCLEOTIDES, MAGNESIUM AND CAFFEINE ON RYANODINE RECEPTOR-BINDING IN RAT-BRAIN

      Journal of neurochemistry
    61. BAINES P; LIMAYE M; HOY T; PADUA RA; WHITTAKER JA; ALSABAH A; BURNETT AK
      DRUG-RESISTANCE IN ACUTE MYELOID-LEUKEMIA

      British Journal of Haematology
    62. GUINN BA; SMITH M; MILLS K; BURNETT A; PADUA RA
      P53 ABNORMALITIES IN LEUKEMIA AND PRELEUKEMIA

      British Journal of Haematology
    63. MCKENNA SL; WHITTAKER JA; PADUA RA; HOLMES JA
      TOPOISOMERASE-II EXPRESSION IN NORMAL HEMATOPOIETIC-CELLS AND CHRONICLYMPHOCYTIC-LEUKEMIA - DRUG SENSITIVITY OR RESISTANCE

      British Journal of Haematology
    64. MCGLYNN H; BAKER AH; RIDGE SA; CACHIA PG; WHITTAKER JA; BURNETT AK; PADUA RA
      FMS MUTATIONS IN PATIENTS IN REMISSION FOLLOWING CYTOTOXIC THERAPY FOR LYMPHOMA AND CHILDHOOD LEUKEMIA

      Blood
    65. PADUA RA; JORDAN ED; CONLON FV; WHITTAKER JA; BURNETT AK
      RETINOIC ACID RECEPTOR ALPHA-GENE REARRANGEMENTS IN MYELODYSPLASTIC SYNDROME (MDS) AND LEUKEMIA

      Blood
    66. PADUA RA; CACHIA PG; TAYLOR C; THOMPSON PW; TENNANT GB; MASTERS G; PETTERSSON T; WHITTAKER JA; BURNETT AK
      NON-DYSPLASTIC MYELODYSPLASIA (MDS)

      Blood
    67. LEWIS DC; WARREN N; SHUKLA VK; GRIMSHAW D; LAIDLER P; PADUA RA
      GROSS REARRANGEMENTS AND DELETIONS OF THE RETINOBLASTOMA GENE ARE RARE IN MALIGNANT-MELANOMA

      Acta dermato-venereologica


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 05/08/20 alle ore 01:35:21